# SIPA1L2

## Overview
SIPA1L2 is a gene that encodes the protein signal-induced proliferation-associated 1 like 2, which is a member of the signal-induced proliferation-associated 1 (SIPA1) protein family, also known as the spine-associated RapGAP (SPAR) family. This protein is characterized by its involvement in GTPase activating protein activity, which plays a crucial role in modulating signaling pathways, particularly those involving Rap1 and Rap2. SIPA1L2 is primarily expressed in the nervous system, where it is integral to synaptic signaling and plasticity, as well as peripheral nerve myelination. The protein contains several conserved domains, including a RapGAP domain, a PDZ domain, and a coiled-coil domain, which facilitate its interactions with other proteins such as Snapin and LC3b, thereby influencing processes like retrograde trafficking and autophagy. Alterations in SIPA1L2 expression or function have been linked to neurological conditions, including Charcot-Marie-Tooth disease type 1A, highlighting its clinical significance in neurobiology (AndresAlonso2019SIPA1L2; Tao2019Variation).

## Structure
The SIPA1L2 protein is a member of the signal-induced proliferation-associated 1 (SIPA1) protein family, also known as the spine-associated RapGAP (SPAR) family. It contains several conserved domains, including an N-terminal RapGAP domain, a PDZ domain, and a C-terminal coiled-coil domain with a leucine zipper (Tao2019Variation). The RapGAP domain is involved in GTPase activating protein activity, which is crucial for modulating signaling pathways such as those involving Rap1 and Rap2 (AndresAlonso2019SIPA1L2). The PDZ domain is important for protein-protein interactions, facilitating the binding of SIPA1L2 to other proteins like Snapin, which is involved in retrograde trafficking (AndresAlonso2019SIPA1L2).

SIPA1L2 also contains a LIR motif (FxxL-motif) within its RapGAP domain, which is essential for binding to LC3b, a marker for autophagosomes. This interaction enhances the catalytic activity of SIPA1L2, promoting retrograde trafficking of TrkB/LC3b complexes (AndresAlonso2019SIPA1L2). The protein is subject to post-translational modifications, such as phosphorylation, which can modulate its activity and interactions, particularly in synaptic signaling (AndresAlonso2019SIPA1L2). The specific structural details, such as the primary amino acid sequence or the three-dimensional conformation, are not detailed in the available context.

## Function
SIPA1L2 is involved in several critical cellular processes, particularly in the nervous system. It plays a significant role in the trafficking and signaling of TrkB-containing amphisomes at presynaptic terminals. These amphisomes are crucial for retrograde signaling, which is important for synaptic function and plasticity, including long-term potentiation (LTP) (AndresAlonso2019SIPA1L2). SIPA1L2 interacts with proteins such as Snapin and LC3b, facilitating the retrograde transport of TrkB-signaling endosomes in axons, which is essential for maintaining synaptic plasticity and neurotransmitter release (AndresAlonso2019SIPA1L2).

In addition to its role in synaptic signaling, SIPA1L2 is involved in peripheral nerve myelination. It regulates the expression of myelin-related genes, including PMP22, and is part of a myelination-associated gene network regulated by the transcription factor SOX10 (Tao2019Variation). SIPA1L2 is expressed in Schwann cells throughout their development and is crucial for maintaining normal myelin gene expression, which is vital for proper nerve function (Tao2019Variation).

SIPA1L2 also interacts with cytoskeletal components such as β-actin and MYH9, suggesting a role in cellular structure and function, particularly in cellular projections and cytoplasmic localization (Tao2019Variation).

## Clinical Significance
Mutations and alterations in the expression of the SIPA1L2 gene have been implicated in several neurological conditions. In Charcot-Marie-Tooth disease type 1A (CMT1A), a common inherited neuropathy, variations in SIPA1L2 have been associated with modifications in disease phenotype. Specifically, four intronic single nucleotide polymorphisms (SNPs) in SIPA1L2 are linked to foot dorsiflexion strength, a key symptom of CMT1A, and are associated with increased risk of severe weakness in the anterior tibialis muscle, leading to foot drop and steppage gait (Tao2019Variation). These genetic variations suggest that SIPA1L2 acts as a genetic modifier in CMT1A, influencing the severity of symptoms (Tao2019Variation).

Research also indicates that SIPA1L2 is involved in neuronal function, particularly in presynaptic plasticity and signaling. In knockout mice, the absence of SIPA1L2 results in deficits in mossy fiber long-term potentiation and spatial pattern separation, processes crucial for cognitive function (AndresAlonso2019SIPA1L2). These findings highlight the potential role of SIPA1L2 in synaptic function and cognitive processes, suggesting its involvement in neurological disorders related to synaptic dysfunction (AndresAlonso2019SIPA1L2).

## Interactions
SIPA1L2 interacts with several proteins, playing a crucial role in neuronal signaling and trafficking. It forms a complex with the TrkB receptor at presynaptic terminals, which is essential for the retrograde transport of signaling endosomes. This interaction is facilitated by the adaptor protein Snapin, which links SIPA1L2 to the dynein motor complex, enabling retrograde trafficking of TrkB-containing amphisomes in axons (AndresAlonso2019SIPA1L2; AndresAlonso2019SIPA1L2a). SIPA1L2 also interacts with LC3b, a component of the autophagosomal machinery, through its RapGAP domain. This interaction enhances the catalytic activity of SIPA1L2, which is crucial for the proper retrograde trafficking of TrkB/LC3b complexes (AndresAlonso2019SIPA1L2).

In addition to its role in neuronal cells, SIPA1L2 has been shown to interact with β-actin and MYH9 in Schwannoma cells, suggesting a role in cellular structure and dynamics. These interactions were confirmed through coimmunoprecipitation and colocalization analyses, indicating that SIPA1L2 is involved in cytoskeletal organization (Tao2019Variation). These interactions highlight SIPA1L2's involvement in both signaling and structural functions within cells.


## References


1. (AndresAlonso2019SIPA1L2) SIPA1L2 controls trafficking and signaling of TrkB-containing amphisomes at presynaptic terminals. This article has 0 citations.

[2. (AndresAlonso2019SIPA1L2a) Maria Andres-Alonso, Mohamed Raafet Ammar, Ioana Butnaru, Guilherme M. Gomes, Gustavo Acuña Sanhueza, Rajeev Raman, PingAn Yuanxiang, Maximilian Borgmeyer, Jeffrey Lopez-Rojas, Syed Ahsan Raza, Nicola Brice, Torben J. Hausrat, Tamar Macharadze, Silvia Diaz-Gonzalez, Mark Carlton, Antonio Virgilio Failla, Oliver Stork, Michaela Schweizer, Eckart D. Gundelfinger, Matthias Kneussel, Christina Spilker, Anna Karpova, and Michael R. Kreutz. Sipa1l2 controls trafficking and local signaling of trkb-containing amphisomes at presynaptic terminals. Nature Communications, November 2019. URL: http://dx.doi.org/10.1038/s41467-019-13224-z, doi:10.1038/s41467-019-13224-z. This article has 66 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-019-13224-z)

[3. (Tao2019Variation) Feifei Tao, Gary W. Beecham, Adriana P. Rebelo, John Svaren, Susan H. Blanton, John J. Moran, Camila Lopez‐Anido, Jasper M. Morrow, Lisa Abreu, Devon Rizzo, Callyn A. Kirk, Xingyao Wu, Shawna Feely, Camiel Verhamme, Mario A. Saporta, David N. Herrmann, John W. Day, Charlotte J. Sumner, Thomas E. Lloyd, Jun Li, Sabrina W. Yum, Franco Taroni, Frank Baas, Byung‐Ok Choi, Davide Pareyson, Steven S. Scherer, Mary M. Reilly, Michael E. Shy, and Stephan Züchner. Variation in sipa1l2 is correlated with phenotype modification in charcot– marie– tooth disease type 1a. Annals of Neurology, 85(3):316–330, February 2019. URL: http://dx.doi.org/10.1002/ana.25426, doi:10.1002/ana.25426. This article has 30 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/ana.25426)